Skip to main content

Dolsten Mikael's Form 4 filing

Pfizer Inc (PFE) · filed Nov 15, 2021

Accession no.
0001225208-21-013883
Filed
Nov 15, 2021
Trade date
Nov 11, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $3.00M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dolsten MikaelCIK 0001437590Officer (President R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 11, 2021Common StockMOption exerciseAcquired+76,135$22.89+$1,742,730.15216,093Direct
Nov 11, 2021Common StockMOption exerciseAcquired+64,841$27.34+$1,772,752.94280,934Direct
Nov 11, 2021Common StockMOption exerciseAcquired+58,572$25.60+$1,499,443.2339,506Direct
Nov 11, 2021Common StockSSaleDisposed−2,124$50.34−$106,922.16337,382Direct
Nov 11, 2021Common StockSSaleDisposed−2,301$50.32−$115,786.32335,081Direct
Nov 11, 2021Common StockSSaleDisposed−3,197$50.29−$160,777.13331,884Direct
Nov 11, 2021Common StockSSaleDisposed−3,396$50.31−$170,852.76328,488Direct
Nov 11, 2021Common StockSSaleDisposed−5,227$50.29−$262,865.83323,261Direct
Nov 11, 2021Common StockSSaleDisposed−6,708$50.33−$337,613.64316,553Direct
Nov 11, 2021Common StockSSaleDisposed−36,711$50.28−$1,845,829.08279,842Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 11, 2021Common StockILess common codeDisposed−47,828$50.18−$2,400,009.0471,314Direct
Nov 11, 2021Common StockMOption exerciseDisposed−153,789$0.00$00Direct
Nov 11, 2021Common StockMOption exerciseDisposed−145,970$0.00$00Direct
Nov 11, 2021Common StockMOption exerciseDisposed−127,160$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)